Clinical Trials
28 trialsSTrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis
Ottawa Hospital Research Institute
CARAVAGGIO
Fadoi Foundation, Italy
PREPOSTEROUS
Helsinki University Central Hospital
A Multicenter, Open-Label, Non-Inferiority Randomized Controlled Trial of Postoperative VTE Prevention in Chinese Patients After Colorectal Cancer Surgery
Beijing Friendship Hospital
PRIORITY
Western University, Canada
WAVe
Ottawa Hospital Research Institute
CANVAS
Alliance Foundation Trials, LLC.
Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery
Roswell Park Cancer Institute
Dalteparin in Preventing DVT in Participants With Cancer
M.D. Anderson Cancer Center
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Academic and Community Cancer Research United
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter
Jonsson Comprehensive Cancer Center
PRIORITY
Asan Medical Center
Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients
G. d'Annunzio University
Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients
M.D. Anderson Cancer Center
ALICAT
Cardiff University
Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery
McMaster University
CASTA-DIVA
Assistance Publique - Hôpitaux de Paris
Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma
University of Southern California
The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients
M.D. Anderson Cancer Center
Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer
Alliance for Clinical Trials in Oncology
PHACS
University of Rochester
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
University of Rochester
COPPVATS
Aarhus University Hospital
Longheva
University Medical Center Groningen
FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer
University of Southern California
FOCUS
Ontario Clinical Oncology Group (OCOG)
Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients
Ontario Clinical Oncology Group (OCOG)